JANE STREET GROUP, LLC

Position in ABUS — Arbutus Biopharma Corp

CIK 1595888 NEW YORK, NY

Back to ABUS Full portfolio

Position in ABUS

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

-$403,717 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

22 quarters on record

Common Shares in ABUS Over Time

Shares Held

Position Value (USD)

Derivatives in ABUS

reported options exposure · as of Mar 31, 2026

CallValue

$148,500

CallShares

33,000

PutValue

$114,750

PutShares

25,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc.	938,699	$53,327,489

All Filings in ABUS

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$114,750	25,500	-50.1%	Put	Defined	2026-05-12
2026-03-31	$148,500	33,000	+223.5%	Call	Defined	2026-05-12
2025-12-31	$403,717	83,933	-72.1%	Shares	Defined	2026-02-12
2025-12-31	$245,791	51,100	+187.1%	Put	Defined	2026-02-12
2025-12-31	$49,062	10,200	-57.5%	Call	Defined	2026-02-12
2025-09-30	$1,364,065	300,455	+34.9%	Shares	Defined	2025-11-14
2025-09-30	$108,960	24,000	-13.4%	Call	Defined	2025-11-14
2025-06-30	$85,593	27,700	-50.4%	Call	Defined	2025-08-14
2025-06-30	$688,439	222,796	-20.6%	Shares	Defined	2025-08-14
2025-03-31	$979,851	280,760	+319.6%	Shares	Defined	2025-05-19
2025-03-31	$62,122	17,800	-92.1%	Put	Defined	2025-05-19
2025-03-31	$195,091	55,900	-56.1%	Call	Defined	2025-05-19
2024-09-30	$257,602	66,910	-67.1%	Shares	Defined	2024-11-15
2024-06-30	$628,498	203,398	+361.0%	Shares	Defined	2024-08-15
2024-03-31	$113,826	44,119	-54.3%	Shares	Defined	2024-05-16
2023-12-31	$241,272	96,509	-29.2%	Shares	Defined	2024-02-15
2023-03-31	$412,952	136,288	+27.9%	Shares	Defined	2023-05-16
2022-12-31	$248,251	106,546	+464.7%	Shares	Defined	2023-02-15
2022-09-30	$36,039	18,869	-55.7%	Shares	Defined	2022-11-15
2022-06-30	$115,448	42,601	-47.9%	Shares	Defined	2022-08-16
2022-03-31	$243,805	81,814	-76.8%	Shares	Defined	2022-05-17
2022-03-31	$672,586	225,700	-14.7%	Put	Defined	2022-05-17
2022-03-31	$379,056	127,200	-44.4%	Call	Defined	2022-05-17
2021-12-31	$890,032	228,800	+341.7%	Call	Defined	2022-02-15
2021-12-31	$1,372,702	352,880	+58.4%	Shares	Defined	2022-02-15
2021-12-31	$1,029,683	264,700	+42.1%	Put	Defined	2022-02-15
2021-09-30	$799,227	186,300	+339.4%	Put	Defined	2021-11-16
2021-09-30	$955,643	222,761	+949.0%	Shares	Defined	2021-11-16
2021-09-30	$222,222	51,800	-13.8%	Call	Defined	2021-11-16
2021-06-30	$64,341	21,235	-60.2%	Shares	Defined	2021-08-16
2021-06-30	$128,472	42,400	-9.6%	Put	Defined	2021-08-16
2021-03-31	$200,133	60,100	-60.6%	Call	Defined	2021-05-18
2021-03-31	$177,694	53,362	+36.6%	Shares	Defined	2021-05-18
2021-03-31	$156,177	46,900	-42.6%	Put	Defined	2021-05-18
2020-12-31	$138,676	39,064	+132.2%	Shares	Defined	2021-02-17
2020-12-31	$290,035	81,700	—	Put	Defined	2021-02-17
2020-12-31	$542,085	152,700	—	Call	Defined	2021-02-17
2020-09-30	$52,661	16,825	-84.2%	Shares	Defined	2020-11-17
2020-06-30	$193,249	106,181	+45.6%	Shares	Defined	2020-08-17
2020-03-31	$73,653	72,925	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.